SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Martin Spallone who wrote (509)1/20/1998 4:57:00 PM
From: FNS  Read Replies (2) of 965
 
Hi Son, looks like your touting your stock on this thread...i don't know much about CYPB's (RA) arthritis drug (Prosorba ???) which was stopped prematurely during Phase III trials via recommendation due to positive safety and efficacy results...and believe they are submitting application for FDA approval!

Bruce, have you heard of this drug/have any comments?

Incidentally, I think CYPB closed around 2 1/2 today (almost doubling in the past week!) -- basically, a recent IPO with 40 million shares outstanding.

In regards to the CNTO class action suit, this is typical of stock companies...unless fraud and/or misrepresentation can be clearly evidenced I can only hope that the company is doing what is deemed best to the comapany and shareholders.

Pancho, hello! Back from Brasil?

FNS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext